readthroughSign in
CompanyELOXNasdaqArlington, MA

Eloxx Pharmaceuticals, Inc.

Eloxx Pharmaceuticals develops small-molecule ribosomal modulators that promote readthrough of premature stop codons from nonsense mutations.

8-KNov 16Latest SEC filing
Nov 16Latest story